| |
| |
|
| Insider
Information: |
Reverberi Gian Piero |
| Relationship: |
SVP & Chief Commercial... |
| City: |
Washington |
| State: |
DC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
165,384 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$807,074 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
165,384 |
|
|
| Total
Value |
$807,074 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
SVP & Chief Commercial... |
2020-03-02 |
165,384 |
2017-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2020-03-02 |
4 |
S |
$10.18 |
$14,755 |
D/D |
(1,450) |
165,384 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2020-01-02 |
4 |
S |
$16.06 |
$18,551 |
D/D |
(1,155) |
166,834 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2019-03-04 |
4 |
S |
$19.92 |
$8,823 |
D/D |
(443) |
167,989 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
S |
$20.17 |
$8,832 |
D/D |
(438) |
168,432 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
168,870 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2019-01-02 |
4 |
S |
$26.28 |
$30,042 |
D/D |
(1,130) |
138,870 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
140,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
110,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
50,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & Chief Commercial Officer |
• – – |
2017-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
